Evidence map›Paper›PMID 21152963›Full record

ArticleInflammation2012

Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells.

Sang-Min Lee, Eun-Ju Kim, Kyoungho Suk, Won-Ha Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sang-Min LeeSchool of Life Sciences and Biotechnology, Kyungpook National University, Daegu, 702-701, South Korea.
Eun-Ju Kim
Kyoungho Suk
Won-Ha Lee
Kyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FasL is a member of the tumor necrosis factor (TNF) superfamily involved in the various immune reactions such as activation-induced cell death, cytotoxic effector function, and establishment of immune privileged sites through its interaction with Fas. On the other hand, FasL is known to transmit a reverse signal that serves as a T cell co-stimulatory signal. However, the role of FasL-mediated reverse signaling in macrophage function has not been investigated. In order to investigate the presence of FasL-mediated signaling in macrophages, the human macrophage-like cell line THP-1 was analyzed after treatment with FasL ligating agents such as recombinant Fas:Fc fusion protein or anti-FasL monoclonal antibody. Stimulation of FasL induced the expression of proinflammatory mediators such as matrix metalloproteinase-9, TNF-α, and IL-8. The specificity of the reaction was confirmed by the transfection of the FasL-specific siRNAs, which suppressed FasL expression as well as the production of proinflammatory mediators. Utilization of various inhibitors of signaling adaptors and ELISA-base nuclear factor (NF)-κB binding assay demonstrated that the signaling initiated from FasL is mediated by mitogen-activated protein kinases including extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase which induce subsequent activation of NF-κB. These data indicate that membrane expression of FasL and its interaction with its counterpart may contribute to the inflammatory activation of macrophages during immune reactions or pathogenesis of chronic inflammatory diseases.

Indexed as

Antibodies, MonoclonalAntigens, SurfaceCell Line, TumorExtracellular Signal-Regulated MAP KinasesFas Ligand Proteinfas ReceptorHumansInterleukin-8JNK Mitogen-Activated Protein KinasesMacrophage ActivationMacrophagesMAP Kinase Signaling SystemMatrix Metalloproteinase 9Membrane GlycoproteinsNF-kappa Bp38 Mitogen-Activated Protein KinasesAntibodies, MonoclonalAntigens, SurfaceCD300C protein, humanExtracellular Signal-Regulated MAP KinasesFASLG protein, humanFas Ligand ProteinFAS protein, humanfas ReceptorInterleukin-8JNK Mitogen-Activated Protein KinasesMatrix Metalloproteinase 9Membrane GlycoproteinsNF-kappa Bp38 Mitogen-Activated Protein KinasesReceptors, FcRecombinant Fusion ProteinsRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID21152963
OpenAlexW2051752888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.